Keyphrases
Israel
92%
Clostridium Difficile Infection
52%
Confidence Interval
43%
Clinical Outcomes
39%
Hospitalized Patients
38%
Bacteremia
35%
Staphylococcus Aureus Bacteremia
35%
Risk Factors
33%
Odds Ratio
32%
Infective Endocarditis
31%
30-day Mortality
28%
Vancomycin
26%
Tertiary Care Hospital
24%
Retrospective Cohort Study
23%
Antibiotics
22%
Clostridium Difficile-associated Diarrhea
21%
Clostridioides Difficile
19%
Methicillin-resistant Staphylococcus Aureus
19%
Klebsiella Pneumoniae Carbapenemase
17%
Multivariate Analysis
17%
Lung Transplantation
16%
Antibiotic Therapy
16%
Polymerase Chain Reaction
15%
Randomized Controlled Trial
15%
Single Center
15%
Invasive Pneumococcal Disease
15%
Pneumonia
14%
Antibiotic Treatment
14%
Gram-negative Bacteremia
14%
Clinical Characteristics
14%
Hospitalization
13%
Adult Patients
13%
COVID-19
13%
Antibiotic Duration
13%
Epidemiology
13%
Trimethoprim-sulfamethoxazole (TMP-SMX)
12%
Influenza
12%
Statins
12%
Clinical Features
12%
Long-term Mortality
12%
Klebsiella Pneumoniae (K. pneumoniae)
11%
Difficile
11%
Mycobacterium Simiae
11%
Obesity
11%
All-cause Mortality
11%
Candida
11%
Mortality Rate
11%
Staphylococcus Aureus
11%
Diarrhea
11%
C. Difficile Toxin
10%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
91%
Antibiotics
49%
Clostridium Difficile Infection
47%
Bacteremia
40%
Retrospective Study
28%
Randomized Controlled Trial
27%
Cohort Study
27%
Staphylococcal Bacteremia
27%
Disease
21%
All Cause Mortality
18%
Gram Negative Sepsis
17%
Staphylococcus Aureus
16%
Vancomycin
16%
Antibiotic Therapy
16%
Infectious Agent
16%
Peptoclostridium difficile
16%
Pneumococcal Infection
15%
Methicillin-Resistant Staphylococcus Aureus
14%
Mortality Rate
14%
Carbapenem
14%
Fluconazole
13%
Methicillin Resistant Staphylococcus Aureus Infection
13%
Cotrimoxazole
13%
Observational Study
13%
Klebsiella pneumoniae
12%
Antibiotic Agent
12%
Gram Negative Bacterium
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Comorbidity
11%
Diarrhea
11%
Antiinfective Agent
10%
Extended Spectrum Beta Lactamase
10%
Endocarditis
10%
Diabetes Mellitus
10%
Seasonal Influenza
9%
Candidemia
9%
Case-Control Study
9%
Bloodstream Infection
9%
Urinary Tract Infection
9%
Statin (Protein)
8%
Antibiotic Associated Diarrhea
8%
Candida
8%
Malignant Neoplasm
8%
Bacterial Endocarditis
7%
Multiple Myeloma
7%
Carbapenem Resistant Enterobacteriaceae
7%
SARS Coronavirus
7%
Immunocompromised Patient
7%
Soft Tissue Infection
7%
Thrombocytopenia
7%
Medicine and Dentistry
Infection
100%
Clostridium Difficile Infection
41%
Retrospective Study
36%
Antibiotic Therapy
31%
Antibiotics
29%
Infective Endocarditis
23%
Pathogen
22%
Bacteremia
21%
Peptoclostridium difficile
19%
Odds Ratio
17%
Polymerase Chain Reaction
17%
Diarrhea
16%
Lung Transplantation
16%
Mortality Rate
15%
Intensive Care Unit
15%
Disease
13%
Retrospective Cohort Study
13%
Randomized Controlled Trial
12%
Staphylococcal Bacteremia
12%
All Cause Mortality
12%
Pneumococcal Infection
11%
Multivariate Analysis
11%
Carbapenem
11%
Gram-Negative Bacteria
11%
Gram Negative Sepsis
11%
Klebsiella pneumoniae
10%
Influenza A
10%
Fluconazole
10%
Staphylococcus Aureus
9%
Bloodstream Infection
9%
Seasonal Influenza
8%
Urinary Tract Infection
8%
Antibiotic-Associated Diarrhea
8%
Diabetes Mellitus
8%
Recurrence Risk
8%
Hemodialysis
8%
Candidemia
8%
Internal Medicine
8%
Cohort Analysis
8%
Cancer
8%
Emergency Department
8%
Pericarditis
7%
Methicillin Resistant Staphylococcus Aureus
7%
Mycobacterium simiae
7%
Multiple Myeloma
7%
Nocardiosis
7%
External Otitis
7%
Antiinfective Agent
7%
Immunoaffinity Chromatography
7%
Triggering Receptor Expressed on Myeloid Cells 1
7%